Publications by authors named "Clay Efferson"

Claim this Profile
E
Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors.
Weisheng Zhang, Brian B Haines, Clay Efferson, Joe Zhu, Chris Ware

Transl Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455).
Yufeng Li, Clay L Efferson, Rajagopal Ramesh, George E Peoples, Patrick Hwu

Cancer Immunol Immunother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Clay L Efferson, Christopher T Winkelmann, Christopher Ware, Timothy Sullivan, Saverio Giampaoli

Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.
Weisheng Zhang, Joe Zhu, Clay L Efferson, Chris Ware, Jennifer Tammam

Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
Naotake Tsuda, David Z Chang, Takashi Mine, Clay Efferson, Adolfo García-Sastre

Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.
Satoshi Ishiyama, Satoko Matsueda, Lovell A Jones, Clay Efferson, Joseph Celestino

Int J Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogen stimulation activates different signaling pathways in early- and late-divided T cells as revealed by cDNA microarray analysis.
Yufeng Li, Kwong-Kwok Wong, Satoko Matsueda, Clay L Efferson, David Z Chang

Int J Mol Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells.
Clay L Efferson, Naotake Tsuda, Kouichiro Kawano, Estanislao Nistal-Villán, Shankhar Sellappan

J Virol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells.
Naotake Tsuda, Kouichiro Kawano, Clay L Efferson, Constantin G Ioannides

Int J Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
Clay L Efferson, Kouichiro Kawano, Naotake Tsuda, Peter Palese, Adolfo García-Sastre

Anticancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death.
Kouichiro Kawano, Clay L Efferson, George E Peoples, Darrick Carter, Naotake Tsuda

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
James L Murray, Michael Gillogly, Kouichiro Kawano, Clay L Efferson, Jeffrey E Lee

Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Byung K Ko, Clay L Efferson, Kouichiro Kawano, Henry M Kuerer, Aysegul Sahin

Int J Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical studies of vaccines targeting breast cancer.
Byung K Ko, Kouichiro Kawano, James L Murray, Mary L Disis, Clay L Efferson

Clin Cancer Res· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene.
Clay L Efferson, Jeanne Schickli, Byung Kyum Ko, Kouichiro Kawano, Sara Mouzi

J Virol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.
Agapito Castilleja, Nancy E Ward, Richard B Epstein, Andrzej P Kudelka, David M Gershenson, Clay L Efferson

Oncol Rep· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex.
Agapito Castilleja, Darrick Carter, Clay L Efferson, Nancy E Ward, Kouichiro Kawano

J Immunol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helper peptide G89 (HER-2:777-789) and G89-activated cells regulate the survival of effectors induced by the CTL epitope E75 (HER-2, 369-377). Correlation with the IFN-gamma: IL-10 balance.
Tom V Lee, Dennis A Johnston, Nicholas Thomakos, Toshie Honda, Clay L Efferson

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis